Semaglutide and tirzepatide do the job by activating GLP-1 receptors in the pancreas to stimulate the production of insulin, which helps to regulate blood sugar ranges in people with kind two diabetes. “GLP-1 https://lilianxkib195691.blogsumer.com/profile